Focal MMP-2 and MMP-9 Activity at the Blood-Brain Barrier Promotes Chemokine-Induced Leukocyte Migration
Although chemokines are sufficient for chemotaxis of various cells, increasing evidence exists for their fine-tuning by selective proteolytic processing. Using a model of immune cell chemotaxis into the CNS (experimental autoimmune encephalomyelitis [EAE]) that permits precise localization of immigr...
Main Authors: | Jian Song, Chuan Wu, Eva Korpos, Xueli Zhang, Smriti M. Agrawal, Ying Wang, Cornelius Faber, Michael Schäfers, Heinrich Körner, Ghislain Opdenakker, Rupert Hallmann, Lydia Sorokin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-02-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124715000625 |
Similar Items
-
How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?
by: Ghislain Opdenakker, et al.
Published: (2022-09-01) -
Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes
by: Berghmans Nele, et al.
Published: (2012-10-01) -
Matrix Metalloproteinase-3 (MMP-3) Is an Endogenous Activator of the MMP-9 Secreted by Placental Leukocytes: Implication in Human Labor.
by: Arturo Flores-Pliego, et al.
Published: (2015-01-01) -
Bivalent Inhibitor with Selectivity for Trimeric MMP-9 Amplifies Neutrophil Chemotaxis and Enables Functional Studies on MMP-9 Proteoforms
by: Elisa Nuti, et al.
Published: (2020-07-01) -
MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus
by: Estefania Ugarte-Berzal, et al.
Published: (2019-03-01)